Our study intended to evaluate the prognostic value of lysyl oxidase (LOX) and its four relevant members, the lysyl oxidase‐like genes (LOXL1‐4), in ovarian cancer (OC) patients with various clinicopathological characteristics, which was based on the Kaplan‐Meier plotter database. The gene discussed is LOX; the disease is ovarian carcinoma.